EXELON NUCLEAR PARTNERS

The S&P 500 broke its longest losing streak in 36 years and regained most of what it had lost since the FBI reignited the e- mail controver...

Under Clinton, pharmaceutical and biotech stocks “could be hit by renewed pressure to curb price increases on drugs,” BlackRock Inc. resear...

Here is a look at the potential winners and losers. But first, a caveat. Investors’ immediate reaction to the US presidential elections oft...